A Multi-Center Study on the Clinical Advantages of Personalized Total Knee Arthroplasty System
- Sponsor
- YujiakuoTHU
- Study ID
- NCT07003035
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to evaluate the clinical benefits of personalized total knee arthroplasty (TKA) in comparison with conventional TKA. The study aims to assess surgical outcomes, functional recovery, complication rates, and cost-effectiveness in a multi-center, prospective cohort study.
Key Dates
- First listed
- Jun 4, 2025
- Start date
- Jun 1, 2025
- Status verified
- May 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 80 participants (estimated)
Arms
- Arm: Cohort 1A total of 80 participants will be enrolled, with 40 receiving personalized total knee arthroplasty and 40 receiving conventional TKA. Participants will be followed for one year post-surgery to assess clinical outcomes.
Primary Outcome Measure
Knee Society Score (KSS) [ Time Frame: At baseline, 6 months, and 12 months post-surgery ]
Find similar trials
Related Studies
- Clinical Orthopaedic Data Bank (Acute and Chronic)Recruiting · University of Florida · Gainesville, Florida
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the ShoulderPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the KneePHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania
- Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the HipPHASE2 · Recruiting · VivaTech International, Inc. · Grove City, Pennsylvania